reglab/statecodes huggingface dataset:
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2416 - Gastrectomy or Vagotomy and Pyloroplasty

Current through Register Vol. 50, No. 6, June 20, 2024
A. Infection in Incision or Inside
				  Abdomen
B. Bleeding which may
				  Require Transfusion
C. Leakage from
				  Stomach (Fistula)
D. Inability to
				  Maintain Weight
E. "Dumping
				  Syndrome" (Chronic Vomiting after Eating)
F. Inability to eat Large Amount of Food,
				  Especially Early after Surgery
G.
				  Diarrhea
H. Need for Vitamin B-12
				  Injections for Life if Total Gastrectomy is Needed
I. Recurrence of Condition for which Surgery
				  was Originally Done
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 40:1299.40(E) et
					 seq.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2418 - Colon Resection

Current through Register Vol. 50, No. 6, June 20, 2024
A. Infection in
				  the Incision
B. Intra-Abdominal
				  Infection (Abscess) Requiring Additional Surgery and Prolonged
				  Hospitalization
C. Leakage from
				  Colon (Fistula) Requiring Additional Surgery and Possible Colostomy (Colon
				  Empties into Bag Worn on the Abdomen)
D. Injury to other Organ or Blood Vessel
				  Requiring Additional Surgery or Blood Transfusion
E. Diarrhea, Sometimes Permanent
F. Hernia in Incision Requiring Additional
				  Surgery for Repair
G. Recurrence of
				  Cancer (if Surgery is done for Cancer)
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 40:1299.40(E) et
					 seq.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2420 - Appendectomy

Current through Register Vol. 50, No. 6, June 20, 2024
A. Infection in the
				  Incision
B. Bleeding from or into
				  Incision
C. Intra-Abdominal
				  Infection (Abscess) Requiring Additional Surgery and Prolonged
				  Hospitalization
D. Leakage from the
				  Colon (Fistula) Requiring Additional Surgery and/or Colostomy (Colon Empties
				  into Bag Worn on the Abdomen)
E.
				  Hernia in the Incision
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 40:1299.40(E) et
					 seq.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2422 - Hernia Repair

Current through Register Vol. 50, No. 6, June 20, 2024
A. Infection in
				  the Incision, Possibly Requiring Additional Surgery to Remove Mesh if used for
				  Repair
B. Bleeding into Incision or
				  Scrotum Resulting in Marked Swelling with Pain, Possibly Requiring Additional
				  Surgery
C. Recurrence of
				  Hernia
D. Injury to or Loss of
				  Testicle(s) or Spermatic Cords(s), Possibly Causing Sterility
E. Nerve Injury Resulting in Numbness or
				  Chronic Pain in Groin Area
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 40:1299.40(E) et
					 seq.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2424 - Hemorrhoidectomy or Excision of Anal Fistula or Fissure

Current through Register Vol. 50, No. 6, June 20, 2024
A. Bleeding at Operative Site
B. Post-Operative Pain, Especially with Bowel
				  Movements
C. Temporary/Permanent
				  Difficulty Controlling Bowel Movements or Passage of Gas
D. Recurrence of Hemorrhoids or Fistula or
				  Fissure
E. Narrowing of Anal
				  Opening Requiring Additional Surgery or Repeated anal Dilatations
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 40:1299.40(E) et
					 seq.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2426 - Excisional Breast Biopsy

Current through Register Vol. 50, No. 6, June 20, 2024
A.
				  Infection;
B. Blood clot
				  (hematoma);
C. Failure to obtain
				  accurate diagnosis;
D. Disfiguring
				  scar;
E. Failure to locate and
				  remove abnormality.
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 40:1299.40(E) et
					 seq.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2428 - Lumpectomy (partial excision of breast) with Axillary Dissection

Current through Register Vol. 50, No. 6, June 20, 2024
A.
				  Infection
B. Blood Clot
				  (Hematoma)
C. Disfiguring
				  Scar
D. Fluid Collection in Axilla
				  (Arm Pit)
E. Numbness to
				  Arm
F. Swelling of Arm on Side of
				  Surgery
G. Damage to nerves of Arm
				  or Chest Wall, Resulting in Pain, Numbness, Weakness
H. Local Recurrence of Cancer
I. Complication of Irradication
AUTHORITY NOTE : Promulgated in accordance with
					 R.S.
					 40:1299.40(E) et
					 seq.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2430 - Intravenous Injection of Radiopaque Contrast Media (both ionic and nonionic)

Current through Register Vol. 50, No. 6, June 20, 2024
A. This
				  procedure has been identified by the Louisiana Medical Disclosure Panel as
				  having no risks that are required to be disclosed. Absence of required
				  disclosure of risks does not mean that consent for the treatment or procedure
				  is not necessary. Furthermore, it may be necessary to disclose risks if a
				  complicating medical condition is present.
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 40:1299.40(E), et
					 seq.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2432 - Ventriculoperitoneal Shunt Placement

Current through Register Vol. 50, No. 6, June 20, 2024
NOTE: Itemization of the procedures and risks under a
					 particular specialty does not preclude other qualified practitioners from using
					 those risks identified for that particular procedure.
A. Malfunction of Shunt Due to
				  Infection
B. Collection of Blood or
				  Fluid between Brain and Skull (Subdural Hematoma/Hygroma)
C. Headaches (Low Pressure
				  Syndrome)
D. Development of
				  Condition Requiring another Shunt (e.g., Isolated Ventricle)
E. Weakness or Loss of Sensation or other
				  Function Due to Placement of Catheter
F. Blood Clot in Brain (Intracerebral
				  Hematoma)
G. Failure to Absorb
				  Fluid from Peritoneal Cavity (Fluid in Abdomen)
H. Blindness, Seizures or Epilepsy
I. Leaks in Catheter And Its
				  Connections
J. Injury to Abdominal
				  Organs
K. Mechanical
				  Failure
L. Separation or Migration
				  of Catheter
M. Infection with or
				  without Malfunction of Shunt
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 40:1299.40(E) et
					 seq.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2434 - Ventricular Atrial Shunt Placement

Current through Register Vol. 50, No. 6, June 20, 2024
A. All of the Material Risks for
				  Ventriculoperitoneal Shunt Placement
B. Heart Failure
C. Infection in Blood Stream
D. Occlusion of Large Veins in
				  Chest
E. Blood or Fluid Collection
				  around Heart
F. Blood Clots in the
				  Lung
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for that particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2436 - Lumboperitoneal Shunt Placement

Current through Register Vol. 50, No. 6, June 20, 2024
A.
				  Inflammation Reaction in Nerves of Spinal Canal
B. Curvature of Spine
C. Shifting/Movement of Brain with
				  Neurological Impairment
D.
				  Headaches
E. Spasticity
F. Difficulty Swallowing
G. Other Neurological Difficulties
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for that particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2438 - Hemodialysis

Current through Register Vol. 50, No. 6, June 20, 2024
A. Hypotension
				  (Abnormally Low Blood Pressure)
B.
				  Blood Vessel Access Problems
C.
				  Anticoagulant Complications such as Hemorrhage
D. Sepsis (Infection in Blood
				  Stream)
E. Cardiac Arrhythmias
				  (Irregular Heartbeats)
F. Allergic
				  Reactions To Tubing And Dialyzer
G.
				  Abdominal Pain
H. Pulmonary Edema
				  (Excess Fluid in Lungs)
I.
				  Hypertension (High Blood Pressure)
J. Systemic Poisoning from Accumulation of
				  Toxic Levels of Metabolic By-Products
K. Air Bubbles in the Bloodstream
L. Abnormal Levels of Minerals in the
				  Blood
M. Acute Hemolysis
N. Seizure
O. Blood Loss
P. Hypothermia (Lowered Body
				  Temperature)
Q. Hyperthermia
				  (Fever)
R. Transfusion
				  Complications, such as Allergic Reaction to Blood Products
S. Metabolic Disorders (Protein Loss,
				  Malnutrition, Elevated Blood Sugar)
T. Acquisition of Viral Infection such as
				  Hepatitis or HIV
U. Cardiac Arrest
				  (Heart Stoppage)
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for that particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2440 - Peritoneal Dialysis

Current through Register Vol. 50, No. 6, June 20, 2024
A. Peritonitis
				  (Infection within the Abdominal Cavity)
B. Catheter Complications (Perforation of an
				  Organ In the Abdomen)
C.
				  Hypotension (Abnormally Low Blood Pressure)
D. Metabolic Disorders (Protein Loss,
				  Malnutrition, Elevated Blood Sugar)
E. Hypertension (High Blood
				  Pressure)
F. Pulmonary Edema
				  (Excess Fluid in Lungs)
G. Cardiac
				  Arrhythmias (Irregular Heartbeats)
H. Cardiac Arrest (Heart Stoppage)
I. Use of Temporary Access Catheter
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for that particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2442 - Insertion of Temporary Hemodialysis Access Catheter

Current through Register Vol. 50, No. 6, June 20, 2024
A. Blood Clots, Requiring
				  Re-Operation
B. Infection
C. False Aneurysm (Damaged Blood Vessel with
				  Swelling And Risk Of Rupture)
D.
				  Recurrent Thrombosis (Blood Clot)
E. Severe Edema Of Extremity
				  (Swelling)
F. Inadequate Blood
				  Supply to Extremity (Interference with Blood Supply)
G. Inadequate Blood Supply to Nerves with
				  Resulting Paralysis
H. Pneumothorax
				  (Air in Chest Cavity Causing Collapse of Lung)
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for that particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2444 - Insertion of Temporary Peritoneal Dialysis Catheter

Current through Register Vol. 50, No. 6, June 20, 2024
A. Peritonitis (Infection inside the
				  Abdominal Cavity)
B.
				  Bleeding
C. Infection
D. Intestinal Perforation (Piercing of an
				  Organ Within the Abdominal Cavity)
E. Ileus (Sluggishness and Distention of
				  Intestines)
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for that particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2446 - Percutaneous Renal Biopsy Complications

Current through Register Vol. 50, No. 6, June 20, 2024
A. Injury to Adjacent Organs, such as Spleen
				  or Liver
B. Infection
C. Hypotension (Abnormally Low Blood
				  Pressure)
D. Bleeding from the
				  Kidney
E. Internal
				  Bleeding
F. Intestinal
				  Perforation
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for that particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2449 - Urology

Current through Register Vol. 50, No. 6, June 20, 2024
A. Nephrectomy
				  (complete or partial removal of kidney)
1.
				  bleeding;
2. infection;
3. injury to adjacent organs such as lung,
				  spleen, liver, bowel, adrenal gland (if not removed);
4. incomplete removal of tumor, if
				  present.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2451 - Gastric Lap Band for Obesity

Current through Register Vol. 50, No. 6, June 20, 2024
A. Risks
				  of Surgery
1. Damage to surrounding organs:
a. bowel, pancreas, liver, requiring more
				  surgery;
b. blood vessels and/or
				  spleen with bleeding requiring transfusion;
c. with removal of spleen.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2453 - Gastric Bypass with or without Liver Biopsy for Obesity

Current through Register Vol. 50, No. 6, June 20, 2024
A. Risks of Surgery:
1. damage to surrounding organs:
a. bowel, pancreas, liver, requiring more
				  surgery;
b. blood vessels and/or
				  spleen with bleeding requiring transfusion;
c. with removal of spleen.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2455 - Thoracentesis (insertion of needle or tube for drainage of chest cavity fluid)

Current through Register Vol. 50, No. 6, June 20, 2024
A.
				  Bleeding
B. Pneumothorax (Lung
				  Collapse)
C. Infection
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for the particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2457 - Cancer Chemotherapy (treatment of cancer using anti-cancer medications)

Current through Register Vol. 50, No. 6, June 20, 2024
A. Hair
				  Loss
B. Damage to Blood Forming
				  Organ (Bone Marrow) which May Result in Bleeding, Infection, Anemia, and
				  Possible Need for Transfusion
C.
				  Damage to Brain, Heart, Kidneys, Liver, Lungs, Nervous System, and
				  Skin
D. Serious Allergic Reaction
				  Including Shock
E.
				  Sterility
F. Nausea and/or
				  Vomiting
G. Constipation or
				  Diarrhea
H. Sores on Lips and/or
				  Ulcers in the Lips, Mouth, Throat, Stomach, Rectum
I. Loss of Lining of Intestinal Tract from
				  Mouth to Anus
J. Secondary Cancer
				  (Cancers in the Future Caused by Chemotherapy)
K. Local Damage at Injection Site
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for the particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2459 - Intravenous Conscious Sedation

Current through Register Vol. 50, No. 6, June 20, 2024
A.
				  The risks for Intravenous Conscious Sedation will be covered by 4 (c), as
				  stated in the main consent form [death, brain damage, disfiguring scars,
				  quadriplegia (paralysis for neck down), paraplegia (paralysis from waist down),
				  the loss or loss of function of any organ or limb, infection, bleeding, and
				  pain].
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for the particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2461 - Cervical Manipulation/Adjustment

Current through Register Vol. 50, No. 6, June 20, 2024
A. Stroke
B. Disc Herniation
C. Soft Tissue Injury
D. Rib Fracture
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: This Section was originally promulgated as
						§2440 but was
						moved as that number was in use.
Note: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for that particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 23 - Informed Consent › Section I-2463 - Thoracic or Lumbar Manipulation/Adjustment

Current through Register Vol. 50, No. 6, June 20, 2024
A. Disc Herniation
B. Soft Tissue Injury
C. Rib Fractures
AUTHORITY NOTE: Promulgated in accordance with
						R.S.
						40:1299.40(E) et seq.
NOTE: This Section was originally promulgated as
						§2442 but was
						moved as that number was in use.
Note: Itemization of the procedures and risks under a
						particular specialty does not preclude other qualified practitioners from using
						those risks identified for that particular
						procedure.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 25 - Departmental Research › Section I-2501 - Purpose

Current through Register Vol. 50, No. 6, June 20, 2024
A. These policies
				  are designed to assure the protection of the rights of human subjects of
				  research conducted in programs or facilities operated or funded by the
				  Department of Health and Hospitals (DHH).
AUTHORITY NOTE:
					 Promulgated in accordance with 56 FR
					 28002.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 25 - Departmental Research › Section I-2503 - Applicability

Current through Register Vol. 50, No. 6, June 20, 2024
A. These policies
				  apply to all research conducted in programs/facilities operated or funded by
				  the DHH.
AUTHORITY NOTE:
					 Promulgated in accordance with 56 FR
					 28002.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 25 - Departmental Research › Section I-2507 - Statement of Principles

Current through Register Vol. 50, No. 6, June 20, 2024
A. The DHH
				  believes that research involving human subjects must be based upon the
				  principles of respect for persons, beneficence, and justice.
1. Respect for persons involves a recognition
				  of personal dignity and autonomy of individuals, and special protection of
				  those persons with diminished autonomy.
2. Beneficence entails an obligation to
				  protect persons from harm by maximizing anticipated benefits and minimizing
				  possible risks of harm.
3. Justice
				  requires that benefits and burdens of research be distributed fairly.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 27 - Capital Area Human Services District › Section I-2701 - Introduction

Current through Register Vol. 50, No. 6, June 20, 2024
A. This agreement
				  is entered into by and between Department of Health and Hospitals, hereinafter
				  referred to as DHH, and Capital Area Human Services District, hereinafter
				  referred to as CAHSD, in compliance with
				  R.S. 46:2661
				  through
				  46:2666 as
				  well as any subsequent legislation.
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 46:2661.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 27 - Capital Area Human Services District › Section I-2703 - Purpose and General Agreement

Current through Register Vol. 50, No. 6, June 20, 2024
A.
				  The Department of Health and Hospitals is authorized by law to provide for the
				  direction, operation, development and management of programs of community-based
				  mental health, mental retardation/developmental disabilities, addictive
				  disorders, public health and related activities for eligible consumers in
				  Louisiana.
B. The legislation
				  authorizes CAHSD to provide services of community-based mental health,
				  developmental disabilities, addictive disorders, public health and related
				  activities for eligible consumers in CAHSD, which includes East Baton Rouge,
				  West Baton Rouge, Ascension, Iberville, East Feliciana, West Feliciana and
				  Pointe Coupee parishes; and to assure that services meet all relevant federal
				  and state regulations; and to provide the functions necessary for the
				  administration of such services.
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 46:2661.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 27 - Capital Area Human Services District › Section I-2705 - Designation of Liaisons

Current through Register Vol. 50, No. 6, June 20, 2024
A. The primary
				  liaison persons under this agreement are:
1.
				  for DHH [] deputy secretary;
2. for
				  CAHSD [] chairperson.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 27 - Capital Area Human Services District › Section I-2709 - Services to be Delivered

Current through Register Vol. 50, No. 6, June 20, 2024
A. In order to
				  provide a broad spectrum of coordinated public services to consumers of the
				  Office of Mental Health, hereinafter referred to as OMH, the Office for
				  Citizens with Developmental Disabilities, hereinafter referred to as OCDD, the
				  Office for Addictive Disorders hereinafter referred to as OAD, the Office of
				  Public Health, hereinafter referred to as OPH and for the District
				  Administration, CAHSD will assume programmatic, administrative and fiscal
				  responsibilities for including, but not limited to, the following:
1. OCDD community services;
2. mental health services consistent with the
				  State Mental Health Plan, as required under the annual Mental Health Block
				  Grant Plan;
3. outpatient treatment
				  (non-intensive) [] OAD;
4.
				  community-based services [] OAD;
5.
				  intensive outpatient treatment/day treatment [] OAD;
6. non-medical/social detoxification []
				  OAD;
7. primary prevention []
				  OAD;
8. adult inpatient treatment
				  services [] OAD;
9. transition to
				  recovery homes (when funds and placements are available);
10. residential board and care (when funds
				  and placements are available) [] OAD.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 27 - Capital Area Human Services District › Section I-2715 - Joint Training and Meetings

Current through Register Vol. 50, No. 6, June 20, 2024
A. CAHSD,
				  through its staff, will participate in DHH and other programmatic trainings,
				  meetings and other activities as agreed upon by CAHSD and DHH. In a reciprocal
				  manner, CAHSD will provide meetings, training sessions, and other activities
				  that will be available for participation by DHH staff as mutually agreed upon
				  by CAHSD and DHH. All program office meetings (trainings, information
				  dissemination, policy development, etc.) discussing/presenting information with
				  statewide implications shall include CAHSD staff.
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 46:2661.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 27 - Capital Area Human Services District › Section I-2717 - Special Provisions

Current through Register Vol. 50, No. 6, June 20, 2024
A. CAHSD
				  agrees to abide by all applicable Federal, State, and Parish laws regarding
				  nondiscrimination in service delivery and/or employment of individuals because
				  of race, color, religion, sex, age, national origin, handicap, political
				  beliefs, disabled veteran, veteran status or any other non-merit
				  factor.
B. CAHSD shall maintain a
				  property control system of all movable property in the possession of CAHSD that
				  was formally under the control of DHH, and of all additional property
				  acquired.
C. For purposes of
				  purchasing, travel reimbursement, and securing of social service/professional
				  contracts, CAHSD shall utilize established written bid/RFP policies and
				  procedures. Such policies and procedures shall be developed in adherence to
				  applicable statutory and administrative requirements. CAHSD shall provide
				  informational copies of such policies and procedures to DHH as
				  requested.
D. CAHSD shall abide by
				  all court rulings and orders that affect DHH and impact entities under CAHSD's
				  control, and shall make reports to DHH's Bureau of Protective Services of all
				  applicable cases of alleged abuse, neglect, exploitation or extortion of
				  individuals in need of protection in a format prescribed by DHH.
E. In the event of a departmental budget
				  reduction in state general funds, or federal funds equivalent, CAHSD shall
				  share in that reduction consistent with other DHH agencies. If reductions occur
				  through Executive Order, DOA, or legislative action in the appropriation
				  Schedule 09, and CAHSD is included in these reductions, then these same
				  reductions shall not be reassessed to CAHSD by DHH agencies.
F. CAHSD shall have membership on the Region
				  II Planning Group and the Statewide Planning Group for the HIV/AIDS Prevention
				  Program. CAHSD shall be a voting member of the Region II Planning Group (RPG).
				  CAHSD shall be a non-voting member of the Statewide Planning Group (SPG) unless
				  the CAHSD member is also elected by the Region II RPG as its official delegate
				  to the SPG. In such case, the CAHSD representative shall vote as the
				  representative of the Region II RPG.
G. CAHSD can obtain a copy of all requests
				  for funding, solicitation of offers, notices of funding availability and other
				  such comparable documents sent out by OPH relative to community-based HIV
				  Prevention and Treatment Services for Region II as well as any such notices
				  received by OPH and not chosen for application by them.
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 46:2661.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 27 - Capital Area Human Services District › Section I-2719 - Renewal/Termination

Current through Register Vol. 50, No. 6, June 20, 2024
A. This agreement
				  will cover the period of time from July 1, 2002 to June 30, 2003.
B. This agreement will be revised on an
				  annual basis, as required by law, and will be promulgated through the
				  Administrative Procedure Act. The annual agreement shall be published in the
				  state register each year in order for significant changes to be considered in
				  the budget process for the ensuing fiscal year.
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 46:2661.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 29 - Organ Procurement › Section I-2901 - Definitions

Current through Register Vol. 50, No. 6, June 20, 2024
A Designated Requestor
-an individual who
					 has completed a course offered or approved by the OPO and designed in
					 conjunction with the tissue and eye bank community in the methodology for
					 approaching potential donor families and requesting organ and tissue
					 donation.
Department
-the Department of Health and
					 Hospitals.
Hospital
-a hospital licensed, accredited,
					 or approved under the laws of any state and includes a hospital operated by the
					 U.S. government, a state, or subdivision thereof, although not required to be
					 licensed under state laws.
Louisiana/Designated Organ Procurement
					 Organization
-the organ procurement organization designated by CMS and
					 recognized by the secretary of the Department of Health and Hospitals of
					 Louisiana under
					 R.S.17:2354.4(J).
Organ Procurement Organization
(
OPO)
-an organization that is designated by the U.S.
					 Department of Health and Human Services, Centers for Medicare and Medicaid
					 Services (CMS), formerly Health Care Financing Administration, or its
					 successor, to perform or coordinate the performance of surgical recovery,
					 preservation, and transportation of organs, and that maintains a system for
					 locating perspective recipients for available organ transplantation.
Tissue Bank or Storage Facility
-a
					 nonprofit facility licensed or approved under the laws of any state for storage
					 of human bodies or parts thereof for use in transplantation to individuals,
					 medical education, research, or therapy.
AUTHORITY NOTE:
					 Promulgated in accordance with
					 R.S.
					 17:2354.4(J), and  42 CFR
					 Part 482.45 .
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 29 - Organ Procurement › Section I-2903 - Conditions for Participation

Current through Register Vol. 50, No. 6, June 20, 2024
A. In order
				  to insure that the family of each potential donor is informed of its options to
				  donate organs, tissues, or eyes or to decline to donate, the department adopts
				  the procedures specified in the federally approved Medicare Conditions for
				  Participation for Hospitals ( 42 CFR Part 482.45) to be followed by all
				  hospitals in Louisiana. The individual designated by the hospital to initiate
				  the request to the family must be an organ procurement representative or a
				  designated requestor.
B. The
				  Department of Health and Hospitals shall recognize the federally designated
				  organ procurement organization. A letter by the CMS shall be presented to the
				  Secretary of the Department of Health and Hospitals upon certification of the
				  organ procurement organization. Any changes between certification periods shall
				  be reported to the secretary within 30 working days.
C. The secretary shall compile and
				  disseminate a list of those nonprofit organ and tissue banks that, in addition
				  to the Louisiana designated OPO, shall be authorized to receive donations under
				  this Section. The organ procurement organization shall be authorized upon
				  designation by the Health Care Finance Administration. The nonprofit tissue
				  bank or eye bank must submit copies of the following to the secretary for
				  authorization:
1. proof that a nonprofit
				  tissue bank or eye bank registered in this state or any state as a 501-C-3
				  charitable organization with no direct ties to any for-profit tissue processor
				  unless an approved nonprofit vehicle is unavailable;
2. a copy of the current accreditation letter
				  by the American Association of Tissue Banking for those nonprofit tissue banks,
				  and a current accreditation letter by the Eye Banks of America Association for
				  the nonprofit eye banks.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 39 - Controlled Dangerous Substances › Subchapter A - Training and Monitoring Requirements › Section I-3901 - Opioid Antagonist Administration and Training

Current through Register Vol. 50, No. 6, June 20, 2024
A. Purpose and Applicability
1.Pursuant to
					 R.S.
					 40:978.2, to protect public health and
					 safety, the Department of Health and Hospitals sets forth the following
					 training and monitoring requirements for a licensed medical practitioner who
					 prescribes, dispenses, or administers naloxone or another opioid antagonist to
					 a person reasonably believed to be undergoing an opioid-related drug
					 overdose.
2.Training and monitoring
					 requirements of this Rule shall apply to licensed medical practitioners when
					 dispensing or distributing opioid antagonists to third parties who will be
					 administering the medication. Training shall include how to recognize signs of
					 overdose indicating when it is appropriate to utilize naloxone or another
					 opioid antagonist, standards for storage and administration of the medication,
					 and instructions for emergency follow-up procedures.
3.First responders as defined in
					 R.S.
					 40:978.1 are exempt from the training
					 requirements as detailed in this Rule.
4.Prescribers are strongly encouraged to
					 co-prescribe naloxone or another opioid antagonist once in a given year to
					 persons receiving opioid therapy for greater than 14 days.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 39 - Controlled Dangerous Substances › Subchapter A - Training and Monitoring Requirements › Section I-3991 - Applicability

Current through Register Vol. 50, No. 6, June 20, 2024
A. To assure
					 maintenance of a drug-free workforce, it shall be the policy of DHH to
					 implement a program of drug testing, in accordance with Executive Order No. MJF
					 98-38,
					 R.S.
					 49:1001, et seq.
,
and all
					 other applicable federal and state laws, as set forth below. This policy shall
					 apply to all employees of DHH including appointees and all other persons having
					 an employment relationship with this agency. Each prospective employee shall be
					 required to submit to drug screening. Pursuant to
					 R.S. 49:1008,
					 a prospective employee who tests positive for the presence of drugs in the
					 initial screening shall be eliminated from consideration for
					 employment.
B. Drug testing
					 pursuant to this policy shall be conducted for the presence of cannabinoids
					 (marijuana metabolites), cocaine metabolites, opiate metabolites,
					 phencyclidine, and amphetamines in accordance with the provisions of
					 R.S.
					 49:1001, et seq
.
DHH
					 reserves the right to test its employees for the presence of any other illegal
					 drug or controlled substance when there is reasonable suspicion to do
					 so.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						49:1015.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 40 - Provider Fees › Section I-4001 - Specific Fees

Current through Register Vol. 50, No. 6, June 20, 2024
A. Definitions
Emergency Ground Ambulance Service
					 Provider
-a non-public, non-federal provider of emergency ground
					 ambulance services.
Net Operating Revenue
-Repealed.
Quarter
-for purposes of this Chapter,
					 quarters shall be constituted as follows.
First Quarter
December, January, February
Second Quarter
March, April, May
Third Quarter
June, July, August
Fourth Quarter
September, October, November
a. Exception.
				  For purposes of hospital and emergency ground ambulance services, quarters
				  shall be constituted as follows.
First Quarter
July, August, September
Second Quarter
October, November, December
Third Quarter
January, February, March
Fourth Quarter
April, May, June
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 40 - Provider Fees › Section I-4003 - Due Date for Submission of Reports and Payment

Current through Register Vol. 50, No. 6, June 20, 2024
A. Quarterly reports and fees shall be
				  submitted to the department and shall be due on the twentieth calendar day of
				  the month following the close of the quarter and shall be deemed delinquent on
				  the thirtieth calendar day of that month. Even if no fee is due, submission of
				  the report is still mandatory.
B.
				  For hospital and emergency ground ambulance services, payment is due 30 days
				  from the notification of the amount owed.
AUTHORITY NOTE:
					 Promulgated in accordance with Chapter 45 of Title 46 as enacted in 1992,
					 46:2601-2605, redesignated as Chapter 47 of Title 46, containing
					 R.S. 46:2621
					 to
					 46:2625
					 and PL
					 102-234.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 40 - Provider Fees › Section I-4005 - Delinquent and/or Unfiled Reports

Current through Register Vol. 50, No. 6, June 20, 2024
A. Penalty Assessment. In the case a report
				  has been determined delinquent, the specific penalty shall be 5 percent of the
				  total fee due on the report for every 30 days that the report is not filed, not
				  to exceed 180 days. When a report is not received within 180 days from the due
				  date, the report shall be deemed not filed and there shall be cause for an
				  audit, investigation or examination to be made by the department.
B. Estimation of Provider Fee Due. In those
				  cases in which a health care provider fails to file the quarterly report, the
				  department will estimate the provider fee due. The department will, by
				  certified mail, notify the provider of the estimated fee due, the method used
				  to calculate the estimated fee and the department's intent to collect the
				  delinquent fee. The provider shall have 15 days from the date of the notice to
				  file a provider fee report with the department. Any provider who fails to file
				  the quarterly report within 15 days of the date of the department's estimated
				  provider fee notice shall waive any and all rights to appeal the department's
				  action and to contest payment of the estimated fee.
C. Incorrect Reporting. If a provider submits
				  a quarterly report required by the provisions of this Chapter and the report
				  made and filed does not correctly compute the amount of the fee owed, there
				  shall be cause for an audit, investigation or examination to be made by the
				  department.
D. False or Fraudulent
				  Reporting. When a provider files a quarterly report that is false or fraudulent
				  or grossly incorrect, there shall be imposed, in addition to any other
				  sanctions allowed under rule or law, a specific penalty of 50 percent of the
				  fee due.
E. Reimbursement of Audit,
				  Hearing, and Witness Costs. If actions by a provider cause the department to
				  examine books, records, or documents, or undertake an audit thereof, and/or
				  conduct a hearing, and/or subpoena witnesses, then the provider shall be
				  assessed an amount as itemized by the department to compensate for all costs
				  incurred in making such examination or audit, and/or in holding such hearing,
				  and/or in subpoenaing and compensating witnesses.
AUTHORITY NOTE:
					 Promulgated in accordance with Chapter 45 of Title 46 as enacted in 1992,
					 46:2601-2605, redesignated as Chapter 47 of Title 46, containing
					 R.S. 46:2621
					 to
					 46:2625
					 and PL
					 102-234.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 40 - Provider Fees › Section I-4007 - Delinquent and/or Unpaid Fees

Current through Register Vol. 50, No. 6, June 20, 2024
A.
				  When the provider fails to pay the fee due, or any portion thereof, on or
				  before the date it becomes delinquent, interest at the rate of 1 1/2 percent
				  per month compounded daily shall be assessed on the unpaid balance until
				  paid.
B. Collection of Delinquent
				  Fees
1. For those health care providers
				  enrolled in the Louisiana Medical Assistance Program (Medicaid), collection of
				  delinquent provider fees will be as follows.
a. The department will withhold from the
				  provider's Medicaid reimbursement, an amount equal to 50 percent of the
				  reimbursement or the actual amount of the delinquent provider fee, including
				  interest and penalty, whichever is less.
b. By enrolling and participating in the
				  Louisiana Medical Assistance Program (Medicaid) a provider agrees that during
				  the period of time delinquent provider fees are being collected, no additional
				  provider fee delinquency will occur. If the provider becomes further
				  delinquent, the department will withhold 100 percent of the Medicaid
				  reimbursement or the actual amount of the delinquent provider fees, including
				  interest and penalty, whichever is less.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 40 - Provider Fees › Section I-4009 - Appeals

Current through Register Vol. 50, No. 6, June 20, 2024
A. Any provider
				  aggrieved pursuant to the provisions determined herein shall have the right to
				  administrative appeal as specified in
				  R.S.
				  46:107.
AUTHORITY NOTE:
					 Promulgated in accordance with Chapter 45 of Title 46 as enacted in 1992,
					 46:2601-2605, redesignated as Chapter 47 of Title 46, containing
					 R.S. 46:2621
					 to
					 46:2625
					 and PL
					 102-234.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 1 - General › Chapter 40 - Provider Fees › Section I-4011 - Exceptions

Current through Register Vol. 50, No. 6, June 20, 2024
A. The secretary
				  may exempt any assessment of penalty and interest described in this
				  Chapter.
AUTHORITY NOTE:
					 Promulgated in accordance with Chapter 45 of Title 46 as enacted in 1992,
					 46:2601-2605, redesignated as Chapter 47 of Title 46, containing
					 R.S. 46:2621
					 to
					 46:2625
					 and PL
					 102-234.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 3 - Licensing and Certification › Chapter 41 - Expedited Licensing Process for Healthcare Facilities and Providers Licensed by the Department of Health › Section I-4101 - Definitions

Current through Register Vol. 50, No. 6, June 20, 2024
Applicant
-any person, partnership,
					 corporation, unincorporated association or other legal entity currently
					 operating, or planning to operate, any of the health care facilities or
					 providers licensed by the Department of Health.
Applicant Representative
-the person
					 specified by the applicant on the application form authorized to respond to
					 inquiries from the Department of Health regarding the expedited licensing
					 process and to whom written notifications are sent relative to the status of
					 the expedited licensing application.
Approval
-a determination by the Department
					 of Health that an application meets the criteria of the expedited licensing
					 process.
Department
-the Louisiana Department of
					 Health (LDH).
Health Standards Section (HSS)
-the section
					 in the Department of Health responsible for licensing health care facilities
					 and agencies, certifying facilities and agencies that apply for participation
					 in the Medicaid (titles XIX and XXI) and Medicare (title XVIII) programs, and
					 conducting surveys and inspections.
Licensing
-deemed to include initial
					 licensing of a provider or facility, licensure upon a change of ownership,
					 licensing due to relocation or replacement facility, or licensing due to adding
					 locations, off-sites, satellites, beds, units, fleet additions or
					 services.
Notification
-deemed to be given on the
					 date on which an applicant representative receives notice from LDH of the
					 expedited license determination, either electronically or by certified mail to
					 the last known address of the applicant representative.
Readiness Date
-the date that the applicant
					 indicates to the HSS field office assigned scheduler that the facility or
					 provider is ready for the licensing survey to be conducted by the
					 department.
AUTHORITY NOTE:
					 Promulgated in accordance with R.S. 36:254 and
					 40:2006.2.
Louisiana Administrative Code › Title 48 - PUBLIC HEALTH-GENERAL › Part I - General Administration › Subpart 3 - Licensing and Certification › Chapter 41 - Expedited Licensing Process for Healthcare Facilities and Providers Licensed by the Department of Health › Section I-4103 - General Provisions

Current through Register Vol. 50, No. 6, June 20, 2024
A. Any
				  person, partnership, corporation, unincorporated association or other legal
				  entity currently operating, or planning to operate, any of the health care
				  facilities or providers licensed by the department may seek an expedited
				  licensing process as provided for in this Chapter.
B. The provisions of this Chapter shall apply
				  to an applicant provider or facility for any of the health care facility or
				  provider types licensed by the department.
C. The expedited licensing process provided
				  for in this Chapter is at the discretion of the applicant provider or facility
				  requesting such expedited process.
1. A
				  request for the expedited licensing process is voluntary.
2. An applicant provider or facility shall
				  not be delayed from the usual licensing and/or survey scheduling process and
				  timeframe, if the expedited licensing process is not requested.